Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Teva
Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Argus Health
Healthtrust
Moodys
Cerilliant
Fuji

Generated: January 17, 2018

DrugPatentWatch Database Preview

SORBITRATE Drug Profile

« Back to Dashboard

Which patents cover Sorbitrate, and when can generic versions of Sorbitrate launch?

Sorbitrate is a drug marketed by Astrazeneca and is included in six NDAs.

The generic ingredient in SORBITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Drug patent expirations by year for SORBITRATE
Medical Subject Heading (MeSH) Categories for SORBITRATE

US Patents and Regulatory Information for SORBITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca SORBITRATE isosorbide dinitrate TABLET, CHEWABLE;ORAL 016776-002 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 088125-001 Aug 21, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 016192-002 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;SUBLINGUAL 016191-002 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET, CHEWABLE;ORAL 016776-003 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 016192-001 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 088124-001 Aug 21, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 086405-002 Aug 21, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;SUBLINGUAL 016191-001 Apr 1, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Dow
Fish and Richardson
Healthtrust
Queensland Health
Citi
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot